| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8785887 | Cancer Treatment Reviews | 2018 | 27 Pages |
Abstract
Overall, the quality of CPGs on treatments for oral cancer is suboptimal. These findings highlight the need to improve CPG development processes and their applicability in this field. Thus, increased efforts are required to enable the development of high-quality evidence-based CPGs for oral cancer.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Meisser Vidal Madera Anaya, Juan Victor Franco, Ángela MarÃa Merchán-Galvis, Carmen R. Gallardo, Xavier Bonfill Cosp,